In addition, enrichment analysis has revealed the therapeutic functions and signalling pathways in mogroside V treatment of ovarian cancer and COVID-19, such as cytokine receptor binding and cytokine activity in biological processes, HIF-1 signalling pathway, and Th17 cell differentiation in molecular mechanisms. Here, HIF1A is linked to ovarian carcinoma.